These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1415024)

  • 1. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion.
    Lopez LR; Santos ME; Espinoza LR; La Rosa FG
    Am J Clin Pathol; 1992 Oct; 98(4):449-54. PubMed ID: 1415024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cardiolipin antibodies (IgG and IgA) in women with recurrent fetal loss correlate to clinical and serological characteristics of SLE.
    Bagger PV; Andersen V; Baslund B; Beck B; Hove H; Høier-Madsen M; Petersen J; Philip J; Schaadt O; Skouby SO
    Acta Obstet Gynecol Scand; 1993 Aug; 72(6):465-9. PubMed ID: 8394626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus.
    Jones HW; Ireland R; Senaldi G; Wang F; Khamashta M; Bellingham AJ; Veerapan K; Hughes GR; Vergani D
    Ann Rheum Dis; 1991 Mar; 50(3):173-5. PubMed ID: 2015010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
    Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders.
    Loizou S; Cofiner C; Weetman AP; Walport MJ
    Clin Exp Immunol; 1992 Dec; 90(3):434-9. PubMed ID: 1458679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.
    Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A
    Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Samarkos M; Davies KA; Gordon C; Loizou S
    Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus.
    Escalante A; Brey RL; Mitchell BD; Dreiner U
    Am J Med; 1995 Jun; 98(6):559-65. PubMed ID: 7778571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticardiolipin antibodies in systemic lupus erythematosus: prevalence and clinical associations].
    Abumohor P; Cerda C; Neira O; Palma S; Alvarado MA; Basualdo J; Bravo M; Guzmán L
    Rev Med Chil; 1991 May; 119(5):517-23. PubMed ID: 1844289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus.
    Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Kobayashi S; Koike T
    Arthritis Rheum; 1996 Sep; 39(9):1466-74. PubMed ID: 8814057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards.
    Cucurull E; Espinoza LR; Mendez E; Molina JF; Molina J; Ordi-Ros J; Gharavi AE
    Lupus; 1999; 8(2):134-41. PubMed ID: 10192508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.